The Growth Rate Of 7.4% To Place Anticancer Drugs Market On The Exponential Growth Curve Between 2018-2026

1
Anticancer Drugs Market
Report Id PMRREP24355 Category Life Science
Healthcare
2
About Persistence Market Research
Customized Research
Persistence Market Research(Persistence Market
Research) is a premier provider of syndicated
research reports, custom research reports, and
consulting services. We deliver a complete
packaged solution, which combines current market
intelligence, statistical anecdotes, technology
inputs, valuable growth insights, aerial view of
the competitive framework, and future market
trends. We provide research services at a global
as well as regional level key regions include
GCC, ASEAN, and BRIC. Our offerings cover a broad
spectrum of industries including Chemicals,
Materials, Energy, Technology, Healthcare, and
Retail. We have a global presence with delivery
centers across India specializing in providing
global research reports and country research
reports. Persistence Market Research is
headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Syndicated Research
Investment Research
Social Media Research
Research Capabilities
Sector Coverage

• Customized Research
• Syndicated Research
• Investment Research
• Social Media Research

• Automotive and Transportation
• Electronics, Semiconductor, and ICT
• Retail and Consumer Products
• Industrial Automation and Equipment

• Chemicals Materials
• Food and Beverages
• Services and Utilities
• Energy, Mining, Oil, and Gas

Subscription Information
For detailed subscription information please
contact Website www.persistencemarketresearch.co
m For sales queries or new topics email us on
sales_at_persistencemarketresearch.com
3
The Growth Rate Of 7.4 To Place Anticancer Drugs
Market On The Exponential Growth Curve Between
2018-2026

• Over the years, there has been an increasing
  emphasis on RD in drug development and therapies
  for the treatment of different types of cancer.
  Pharmaceutical companies are introducing novel
  drug formulations in the global market, thereby
  expanding the product pipeline for cancer
  treatment. This is likely to create newer vistas
  of growth in the anticancer drugs market.
• This report published by Persistence Market
  Research throws light on the revenue projections
  of the global market for anticancer drugs, which
  is estimated to reach a whopping valuation of US
  227 Bn by the end of 2026, up from just under US
  129 Bn in 2018. This is indicative of a growth
  rate of 7.4 during the period from 2018 to 2026.
• Companies operating in the global anticancer
  drugs market are also seeking the necessary
  regulatory approvals for multiple indications to
  ensure a maximum return on their investment from
  a single molecular entity. Immuno-oncology is
  currently the most active area in cancer research
  and doctors and research scientists across the
  world are collaborating to develop newer ways to
  use immuno-oncology to treat various types of
  cancers.

Get Sample Copy of Report _at_ https//www.persistenc
emarketresearch.com/samples/24355
4
Newer Cancer Treatment Options and an
Ever-increasing Drugs Pipeline Owing to the
Current Spate of Ongoing Clinical Trials to Bode
Well for the Anticancer Drugs Market
In the last five years, 70 new cancer treatment
options have been introduced in the global market
and are used by healthcare facilities to treat
more than 20 different types of tumors.
Innovation is fueling the pipeline of oncology
drugs in clinical development and this is only
expected to increase in the near future. The
pipeline of anticancer drugs in different stages
of clinical development has expanded
significantly in the last decade, with clinical
trials for immunotherapies being the fastest
growing within oncology RD and likely to lead
the drugs pipeline by 2020. This indicates the
rising demand for anticancer drugs in the global
healthcare sector, pushing companies to speed up
drugs development and clinical trials and also
seek the necessary regulatory approvals. This
factor is expected to augment revenues in the
global anticancer drugs market.
Access Full Report _at_ https//www.persistencemarket
research.com/checkout/24355
5
(No Transcript)